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Background: Ranolazine (RAN) increases exercise duration and time to angina onset and decreases angina frequency in patients with chronic 
angina without effect on heart rate and aortic blood pressure. We hypothesized that RAN relieves myocardial ischemia by decreasing cardiac work 
through its negative inotropic effect.
methods: Non-flow limiting stenosis was created in the left anterior descending coronary artery (LAD) in 17 open-chest dogs. The left circumflex 
bed was the normal control region. We compared changes in hemodynamic measurements, global myocardial function (peak LV dP/dt), regional 
myocardial function (radial strain using speckle-tracking echocardiography), and regional myocardial blood flow (contrast echocardiography) in the 
absence and presence of intravenous RAN at rest and during dobutamine stress.
results: In the presence of a non-critical coronary stenosis, RAN significantly reduced mean aortic blood pressure, rate pressure product, peak LV 
dP/dt, and LAD coronary artery pressure, but had no effect on myocardial blood flow both at rest and during dobutamine stress. While radial strain 
was not different with RAN in absolute terms, the magnitude of LAD radial strain increase was significantly greater in the presence of RAN. (Table 1).
conclusion: Ranolazine acutely decreased myocardial work by decreasing global contractility and rate-pressure product without altering 
myocardial blood flow. This resulted in beneficial effect on regional function during ischemia.
 
